Prelude Capital Management’s Aveanna Healthcare AVAH Stock Holding History

Prelude Capital Management’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Sell	14,500 -24,146	-62%	-$170K	0.01%	1078
2026 Q1	$249K	Buy	38,646 +708	+2%	+$5.47K	0.02%	799
2025 Q4	$310K	Buy	37,938 +6,317	+20%	+$57.1K	0.02%	779
2025 Q3	$280K	Buy	31,621 +4,385	+16%	+$27.7K	0.02%	767
2025 Q2	$142K	Buy	27,236 +13,408	+97%	+$68.2K	0.01%	864
2025 Q1	$74.9K	Buy	+13,828	New	+$65.2K	0.01%	1064
2022 Q2	–	Sell	-33,900	Closed	-$116K	–	1810
2022 Q1	$116K	Sell	33,900 -12,400	-27%	-$67.3K	﹤0.01%	1383
2021 Q4	$343K	Buy	46,300 +300	+0.7%	+$2.18K	0.01%	1237
2021 Q3	$369K	Sell	46,000 -1,793	-4%	-$17.4K	0.01%	1037
2021 Q2	$591K	Buy	+47,793	New	+$567K	0.02%	858

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prelude Capital Management's AVAH Position: Q2 2026 in Review

Prelude Capital Management reduced its Aveanna Healthcare (AVAH) stake by 62% in Q2 2026, selling an estimated $170K and leaving 14,500 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #1078.

Prelude Capital Management first reported a position in AVAH in Q2 2021 and has held it in 10 quarters since. The position peaked at $591K in Q2 2021. 216 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

Prelude Capital Management held 14,500 shares of Aveanna Healthcare worth $124K as of Q2 2026.
Prelude Capital Management sold 24,146 Aveanna Healthcare shares in Q2 2026, an estimated $170K.
Aveanna Healthcare made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1078 holding.
Prelude Capital Management first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 10 quarters since.
Prelude Capital Management's Aveanna Healthcare position peaked at $591K in Q2 2021.
216 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.